The presence of anti-citrullinated protein antibodies (ACPA) does not affect the clinical response to adalimumab in a group of RA patients with the tumor necrosis factor (TNF) α-308 G/G promoter polymorphism
Soto Sáez, Lilian; Sabugo Siraqyan, María Francisca; Catalán Martina, Diego; Wurmann Kiblisky, Pamela; Cermenatti, Tomás; Gatica Rossi, Héctor; Aravena, Octavio; Salazar, Lorena; Aguillón Gutiérrez, Juan Carlos; Cuchacovich Turteltaub, Miguel (Springer, 2011)